Skip to content

PROSTATE ONCOLOGY SPECIALISTS

P/ 310-827-7707 | F/ 310-574-4002 | MAIL@PROSTATEONCOLOGY.COM

Menu
  • About
  • Services
  • Prostate Pros
  • Blog
  • Contact

Category: High Risk

Azure (High-Risk) also contains three subtypes. Low-Azure is Gleason 4+4=8 with all other criteria being favorable—two or less positive biopsy cores, no biopsy core more than 50% involved with cancer, a PSA less than 10 and minimal or no palpable disease (T1c or T2a). Men with Low-Azure can consider having treatment along the lines of what is used for High-Teal. High-Azure is defined by having at least one of the following: A PSA over 40, Gleason 9 or 10, more than 50 percent positive biopsy cores, or cancer that spreads overtly outside the prostate. Basic-Azure falls between the Low and High subtypes. Basic-Azure is managed aggressively with and extended duration of hormonal therapy, seeds and IMRT as is High-Azure, possibly though with the addition of Zytiga and or Taxotere.

Advanced / Azure / Elevated / High Risk / Indigo / Intermediate Risk / Low Risk / Newly Diagnosed / Prostate Cancer / Royal / Stages / Teal

Testosterone Inactivating Pharmaceuticals (TIP)

BY MARK SCHOLZ, MD Hormones play a large role in cancer growth.  They are also integral to treatment.  Testosterone is a key player. It originates mostly in the testicles and, …

Advanced / Azure / Elevated / High Risk / Indigo / Intermediate Risk / Low Risk / Newly Diagnosed / Prostate Cancer / Relapsed / Royal / Sky / Stages / Teal

Making an Informed Decision about Prostate Cancer

BY MARK SCHOLZ, MD What Is the Best Therapy for Me? This is one of the greatest questions for men with prostate cancer. How do you arrive at a reliable …

Advanced / Azure / Elevated / High Risk / Indigo / Intermediate Risk / Low Risk / Newly Diagnosed / Prostate Cancer / Relapsed / Royal / Sky / Stages / Teal / Undiagnosed

Diet, Fitness and Supplements for Men with Prostate Cancer

BY MARK SCHOLZ, MD Unhealthy diets encourage prostate cancer’s growth and spread.  Consider Asia, where mortality from prostate cancer is eighteen times lower than in the United States.  Genetic factors …

Advanced / Azure / Elevated / High Risk / Indigo / Intermediate Risk / Low Risk / Newly Diagnosed / Prostate Cancer / Relapsed / Royal / Sky / Stages / Teal / Undiagnosed

Advances in Testing for Prostate Cancer

When I was 10 years old, my mother lost a close friend to cancer.  I was too young to know anything about serious illness, but when I asked her why …

Verywell logo
Advanced / Azure / Elevated / High Risk / Indigo / Intermediate Risk / Low Risk / Newly Diagnosed / Prostate Cancer / Relapsed / Royal / Sky / Stages / Teal

Alternative Therapies for Prostate Cancer

BY MARK SCHOLZ, MD Being diagnosed with cancer often stimulates people into action and triggers powerful survival instincts. Numerous purveyors of alternative medicine cater to these natural fears, and in …

Verywell logo
Advanced / Azure / Elevated / High Risk / Indigo / Intermediate Risk / Low Risk / Newly Diagnosed / Prostate Cancer / Relapsed / Royal / Sky / Stages / Teal / Undiagnosed

10 Myths of Prostate Cancer

BY MARK SCHOLZ, MD I have cared for prostate cancer patients for more than 20 years. Patients come to me with all kinds of wrong notions. Here are 10 of …

Verywell logo
High Risk / Intermediate Risk / Prostate Cancer

Proton Radiation Therapy for Prostate Cancer

BY MARK SCHOLZ, MD Proton radiation is an enhanced type of radiation gaining in popularity for the treatment of prostate cancer. Men who are contemplating proton radiation need to compare …

Verywell logo
Advanced / Azure / High Risk / Indigo / Intermediate Risk / Low Risk / Newly Diagnosed / Prostate Cancer / Relapsed / Royal / Sky / Teal

10 Ways to Cope With Prostate Cancer: How to Achieve the Best Outcome

BY MARK SCHOLZ, MD Every year, 200,000 men are diagnosed with prostate cancer. Confusion about optimal treatment is widespread. The doctors even defer to their patients saying, “Since it’s about …

Verywell logo
Advanced / High Risk / Intermediate Risk / Relapsed

Axumin PET Scans: A Breakthrough for Prostate Cancer

BY MARK SCHOLZ, MD Axumin is an FDA-approved, Medicare-covered scan that can achieve early detection of recurrent prostate cancer after surgery or radiation. For years we have been able to …

Verywell logo
Advanced / Elevated / High Risk / Intermediate Risk / Low Risk / Newly Diagnosed / Prostate Cancer / Undiagnosed

Is It Possible to Substitute a Scan for Prostate Biopsy?

BY MARK SCHOLZ, MD There are two different ways to do a prostate biopsy –  targeted and random. The random 12-core prostate biopsy is standard and has been in use for over …

Posts navigation

Older posts
Newer posts

SCHEDULE AN APPOINTMENT

PHONE 310-827-7707
FAX 310-574-4002
mail@prostateoncology.com

  • New Patient Application
  • Education
  • Clinical Trials

Categories

  • Advanced
  • Elevated
  • High Risk
  • Intermediate Risk
  • Low Risk
  • Newly Diagnosed
  • Other
  • Prostate Cancer
  • Relapsed
  • Stages
    • Azure
    • Indigo
    • Royal
    • Sky
    • Teal
  • Undiagnosed

Recent Posts

  • PSA Screening Flowchart
  • A Few Thoughts on Prostatitis
  • Considering Prostate Cancer Clinical Trials? Here’s What You Need to Know
  • Prostate Cancer Spotlights in 2020: A Year in Review
  • Find out about PSMA PET Imaging on Prostate Pros Podcast

Archives

  • April 2021
  • February 2021
  • January 2021
  • December 2020
  • October 2020
  • September 2020
  • August 2020
  • July 2020
  • June 2020
  • May 2020
  • April 2020
  • March 2020
  • February 2020
  • January 2020
  • December 2019
  • November 2019
  • October 2019
  • September 2019
  • August 2019
  • July 2019
  • June 2019
  • May 2019
  • April 2019
  • March 2019
  • January 2019
  • December 2018
  • October 2018
  • September 2018
  • August 2018
  • July 2018
  • June 2018
  • May 2018
  • March 2018
  • January 2018
  • December 2017
  • November 2017
  • October 2017
  • September 2017
  • August 2017
  • July 2017
  • May 2017
  • February 2017
  • November 2016
  • October 2016
  • September 2016
  • August 2016
  • July 2016
  • May 2016
  • April 2016
  • February 2016
  • January 2016
  • October 2015
  • November 2012
  • January 2012
  • April 2011
Join our Newsletter
Keep Updated
Copyright © 2025 PROSTATE ONCOLOGY SPECIALISTS – OnePress theme by FameThemes